| abstract |
The present invention is useful for inhibiting the delta isoform of PI3K and is a compound of formula (I) for treating disorders mediated by lipid kinases such as inflammation, immune diseases and cancer, and stereoisomers, geometric isomers, tautomers, Metabolites and pharmaceutically acceptable salts. The invention also relates to the use of the compounds of formula (I) in the diagnosis, prevention or treatment of in vitro, in situ and in vivo of such disorders or associated pathological symptoms in mammalian cells. (I) |